Kandenko Co.,Ltd.
Kandenko Co.,Ltd. (1942.T) Financial Performance & Income Statement Overview
Explore the financials of Kandenko Co.,Ltd. (1942.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Kandenko Co.,Ltd. (1942.T) Income Statement & Financial Overview
Analyze Kandenko Co.,Ltd.’s 1942.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $216.40B | $168.75B | $157.88B | $128.86B |
| Cost of Revenue | $187.60B | $144.43B | $135.55B | $111.39B |
| Gross Profit | $28.80B | $24.32B | $22.32B | $17.48B |
| Gross Profit Ratio | $0.13 | $0.14 | $0.14 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $12.40B | $7.82B | $7.25B | $7.13B |
| Operating Expenses | $12.40B | $7.82B | $7.25B | $7.13B |
| Total Costs & Expenses | $200.002B | $152.25B | $142.80B | $118.51B |
| Interest Income | $56.00M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $69.00M | $0.00 | $42.00M | $57.00M |
| Depreciation & Amortization | $2.67B | $2.45B | $2.38B | -$10.35B |
| EBITDA | $16.88B | $18.72B | $17.37B | $757.00M |
| EBITDA Ratio | $0.08 | $0.11 | $0.11 | $0.006 |
| Operating Income | $16.39B | $16.50B | $15.07B | $10.35B |
| Operating Income Ratio | $0.08 | $0.10 | $0.10 | $0.08 |
| Other Income/Expenses (Net) | -$2.48B | $5.34B | -$241.00M | $698.00M |
| Income Before Tax | $13.91B | $21.84B | $14.83B | $11.05B |
| Income Before Tax Ratio | $0.06 | $0.13 | $0.09 | $0.09 |
| Income Tax Expense | $2.66B | $6.98B | $4.68B | $3.59B |
| Net Income | $10.48B | $14.63B | $9.88B | $7.38B |
| Net Income Ratio | $0.05 | $0.09 | $0.06 | $0.06 |
| EPS | $51.29 | $71.59 | $48.35 | $36.12 |
| Diluted EPS | $51.29 | $71.59 | $48.35 | $36.12 |
| Weighted Avg Shares Outstanding | $204.38M | $204.40M | $204.37M | $204.38M |
| Weighted Avg Shares Outstanding (Diluted) | $204.38M | $204.40M | $204.37M | $204.38M |
The company's financials show resilient growth, with revenue advancing from $128.86B in Q1 2024 to $216.40B in Q4 2024. Gross profit remained healthy with margins at 13% in Q4 2024 compared to 14% in Q1 2024. Operating income hit $16.39B last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $16.88B. Net income dropped to $10.48B, while earnings per share reached $51.29. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan